Tag: Vadiraja PS
Trilegal acts for JB Pharmaceuticals on Novartis acquisition
Trilegal advised JB Pharmaceuticals in its acquisition of a portfolio of specific ophthalmology brands from Novartis for INR10.9 billion
Trilegal advised JB Pharmaceuticals in its acquisition of a portfolio of specific ophthalmology brands from Novartis for INR10.9 billion
Chris Parsons shares his reflections on the Indian legal market’s transformation from 2005 to 2025
Follow us on LinkedIn